Table 1.
Key patient characteristics at enrolment
| Characteristics at enrolment | Study cohort (n=746)* |
| Age at enrolment (years), mean (SD) | 53.7 (14.5) |
| Gender, n (%) | |
| Male | 171 (22.9) |
| Female | 286 (38.3) |
| Unknown | 289 (38.7) |
| Benralizumab injections received in hospital prior to PSP enrolment | |
| N (%) | |
| 0 | 1 (0.1) |
| 1–3 | 257 (34.5) |
| 4+ | 213 (28.6) |
| Unknown | 275 (36.8) |
| Mean (SD) | |
| Service registration status, n (%) | |
| Biologic naïve | 123 (16.5) |
| Biologic experienced | 573 (76.8) |
| Existing–transfer | 8 (1.1) |
| Change of therapy | 4 (0.5) |
| Unknown | 38 (5.1) |
| Service choice at enrolment, n (%) | |
| Delivery only | 30 (4.0) |
| Delivery and nurse administration service | 4 (0.5) |
| Delivery and self-injection training | 209 (28.0) |
| Additional service support including ACQ-6 | 477 (63.9) |
*All patients enrolled in PSP and consenting.
ACQ-6, 6-item Asthma Control Questionnaire; PSP, patient support programme.